Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants.
Saved in:
| Title: | Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants. |
|---|---|
| Authors: | Goldblatt D; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom. Electronic address: d.goldblatt@ucl.ac.uk., Andrews NJ; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom., Sheppard CL; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom., Rose S; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom., Roalfe L; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom., Southern J; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom., Pearce E; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom., Johnson M; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom., Litt DJ; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom., Fry NK; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom., Waight P; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom., Miller E; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom. |
| Source: | Vaccine [Vaccine] 2023 May 05; Vol. 41 (19), pp. 3019-3023. Date of Electronic Publication: 2023 Apr 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37045683 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goldblatt+D%22">Goldblatt D</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom. Electronic address: d.goldblatt@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Andrews+NJ%22">Andrews NJ</searchLink>; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sheppard+CL%22">Sheppard CL</searchLink>; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rose+S%22">Rose S</searchLink>; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Aley+PK%22">Aley PK</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Roalfe+L%22">Roalfe L</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Southern+J%22">Southern J</searchLink>; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Robinson+H%22">Robinson H</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pearce+E%22">Pearce E</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Plested+E%22">Plested E</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Johnson+M%22">Johnson M</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Litt+DJ%22">Litt DJ</searchLink>; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fry+NK%22">Fry NK</searchLink>; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Waight+P%22">Waight P</searchLink>; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Snape+MD%22">Snape MD</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Miller+E%22">Miller E</searchLink>; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2023 May 05; Vol. 41 (19), pp. 3019-3023. <i>Date of Electronic Publication: </i>2023 Apr 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37045683 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2023.04.017 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3019 Titles: – TitleFull: Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goldblatt D – PersonEntity: Name: NameFull: Andrews NJ – PersonEntity: Name: NameFull: Sheppard CL – PersonEntity: Name: NameFull: Rose S – PersonEntity: Name: NameFull: Aley PK – PersonEntity: Name: NameFull: Roalfe L – PersonEntity: Name: NameFull: Southern J – PersonEntity: Name: NameFull: Robinson H – PersonEntity: Name: NameFull: Pearce E – PersonEntity: Name: NameFull: Plested E – PersonEntity: Name: NameFull: Johnson M – PersonEntity: Name: NameFull: Litt DJ – PersonEntity: Name: NameFull: Fry NK – PersonEntity: Name: NameFull: Waight P – PersonEntity: Name: NameFull: Snape MD – PersonEntity: Name: NameFull: Miller E IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2023 May 05 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 41 – Type: issue Value: 19 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
